Fibrocell Science Company Profile (NASDAQ:FCSC)

About Fibrocell Science

Fibrocell Science logoFibrocell Science, Inc. is an autologous cell and gene therapy company. The Company is focused on discovering and developing localized therapies for diseases affecting the skin, connective tissue and joints. Its product candidate, azficel-T, is in development to treat patients suffering from vocal cord scarring that is either idiopathic or age-related. It is investigating the indication in a Phase II clinical trial. Its gene-therapy product candidate, FCX-007, is in pre-clinical development for the treatment of recessive dystrophic epidermolysis bullosa. Its gene-therapy product candidate, FCX-013, is in pre-clinical development for the treatment of linear scleroderma. Its product, LAVIV (azficel-T), is indicated for the improvement of the appearance of moderate to severe nasolabial fold wrinkles in adults. A third gene-therapy program is focused on the treatment of arthritis. Its product, LAVIV (azficel-T), is focused on improving the appearance of nasolabial fold wrinkles in adults.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drugs - Generic
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: FCSC
  • CUSIP:
Key Metrics:
  • Previous Close: $0.92
  • 50 Day Moving Average: $1.08
  • 200 Day Moving Average: $1.88
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -2.17
  • P/E Growth: 0.00
  • Market Cap: $39.07M
  • Outstanding Shares: 43,898,000
  • Beta: 0.43
Additional Links:
Companies Related to Fibrocell Science:

Analyst Ratings

Consensus Ratings for Fibrocell Science (NASDAQ:FCSC) (?)
Ratings Breakdown: 1 Hold Rating, 3 Buy Ratings
Consensus Rating:Buy (Score: 2.75)
Consensus Price Target: $5.63 (532.02% upside)

Analysts' Ratings History for Fibrocell Science (NASDAQ:FCSC)
Show:
DateFirmActionRatingPrice TargetDetails
8/7/2016Canaccord GenuityReiterated RatingBuy$1.50View Rating Details
7/6/2016Griffin SecuritiesReiterated RatingBuy$12.00View Rating Details
6/8/2016Roth CapitalReiterated RatingBuy$5.00View Rating Details
6/8/2016WedbushReiterated RatingNeutral$1.50 -> $4.00View Rating Details
(Data available from 8/26/2014 forward)

Earnings

Earnings History for Fibrocell Science (NASDAQ:FCSC)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
11/3/2016        
8/4/2016Q216($0.15)($0.18)ViewN/AView Earnings Details
5/5/2016Q1($0.15)($0.03)ViewN/AView Earnings Details
3/10/2016Q415($0.17)($0.40)ViewListenView Earnings Details
11/5/2015Q315($0.16)($0.07)ViewN/AView Earnings Details
8/6/2015Q215($0.16)($0.17)ViewN/AView Earnings Details
5/8/2015($0.16)($0.17)ViewN/AView Earnings Details
3/13/2015($0.16)($0.08)ViewN/AView Earnings Details
11/7/2014Q3 14($0.14)($0.17)ViewN/AView Earnings Details
8/11/2014($0.18)($0.08)ViewN/AView Earnings Details
5/19/2014Q114($0.15)($0.35)ViewN/AView Earnings Details
3/17/2014Q414($0.26)($0.14)ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Fibrocell Science (NASDAQ:FCSC)
Current Year EPS Consensus Estimate: $-0.5 EPS
Next Year EPS Consensus Estimate: $-0.41 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20163($0.18)($0.14)($0.16)
Q2 20163($0.22)($0.09)($0.15)
Q3 20163($0.19)($0.06)($0.12)
Q4 20163($0.22)($0.07)($0.13)
Q1 20174($0.20)($0.07)($0.13)
Q2 20174($0.20)($0.07)($0.13)
Q3 20174($0.21)($0.05)($0.13)
Q4 20173($0.17)($0.05)($0.10)
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Fibrocell Science (NASDAQ:FCSC)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Fibrocell Science (NASDAQ:FCSC)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/13/2015David PernockCEOBuy3,000$5.00$15,000.00View SEC Filing  
8/11/2015David PernockCEOBuy3,500$6.54$22,890.00View SEC Filing  
7/27/2015Randal J KirkMajor ShareholderBuy975,987$5.80$5,660,724.60View SEC Filing  
5/13/2015David PernockCEOBuy16,600$4.30$71,380.00View SEC Filing  
12/12/2014David PernockCEOBuy5,000$2.52$12,600.00View SEC Filing  
11/20/2014David PernockCEOBuy5,000$2.54$12,700.00View SEC Filing  
11/20/2014John Michael MaslowskiVPBuy1,000$2.54$2,540.00View SEC Filing  
6/5/2014Christine St.ClareDirectorBuy10,000$3.00$30,000.00View SEC Filing  
6/5/2014David PernockCEOBuy12,500$2.95$36,875.00View SEC Filing  
6/4/2014Kelvin MooreDirectorBuy4,557$2.99$13,625.43View SEC Filing  
6/4/2014Randal J KirkMajor ShareholderBuy400,000$2.90$1,160,000.00View SEC Filing  
1/24/2014Randal J KirkMajor ShareholderBuy1,024,590$4.88$4,999,999.20View SEC Filing  
11/21/2013David PernockCEOBuy10,000$3.69$36,900.00View SEC Filing  
11/20/2013Gregory L WeaverCFOBuy10,000$3.51$35,100.00View SEC Filing  
10/1/2013Randal J KirkMajor ShareholderBuy3,658,536$4.10$14,999,997.60View SEC Filing  
7/26/2013Randal J KirkMajor ShareholderBuy1,243,781$6.03$7,499,999.43View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Fibrocell Science (NASDAQ:FCSC)
DateHeadline
investornewswire.com logoFibrocell Science Inc (NASDAQ:FCSC) Gets 0 Recommendations To Sell - Investor Newswire (NASDAQ:FCSC)
www.investornewswire.com - August 25 at 9:58 AM
capitalcube.com logoETF’s with exposure to Fibrocell Science, Inc. : August 23, 2016 (NASDAQ:FCSC)
www.capitalcube.com - August 23 at 5:07 PM
News IconShares Dipping Lower in Trade: Fibrocell Science, Inc. (NASDAQ:FCSC) - Post News (NASDAQ:FCSC)
www.kentuckypostnews.com - August 22 at 5:02 PM
investornewswire.com logoWill Fibrocell Science Inc (NASDAQ:FCSC) Hit $12 Price Target? - Investor Newswire (NASDAQ:FCSC)
www.investornewswire.com - August 18 at 5:37 AM
finance.yahoo.com logoFIBROCELL SCIENCE, INC. Financials (NASDAQ:FCSC)
finance.yahoo.com - August 13 at 4:53 PM
capitalcube.com logoETF’s with exposure to Fibrocell Science, Inc. : August 11, 2016 (NASDAQ:FCSC)
www.capitalcube.com - August 11 at 5:09 PM
News IconFibrocell Science Inc (NASDAQ:FCSC) & RR Donnelley & Sons Co (NASDAQ:RRD) Market Movers - Money News (press release) (NASDAQ:FCSC)
www.newsismoney.com - August 10 at 11:11 PM
streetinsider.com logoFibrocell Science (FCSC) Announces $25M Conv. Debt, Warrants Offering; Terminates Stock Offering (NASDAQ:FCSC)
www.streetinsider.com - August 10 at 12:22 PM
investors.com logoFibrocell Science relaunches funding with convertible debt not equity (NASDAQ:FCSC)
www.proactiveinvestors.com - August 10 at 12:22 PM
publicnow.com logoIntrexon Announces Second Quarter and First Half 2016 Financial Results (NASDAQ:FCSC)
www.publicnow.com - August 9 at 9:18 PM
streetinsider.com logoFibrocell Science (FCSC) Announces $25M Conv. Debt, Warrants Offering; Terminates Stock Offering - StreetInsider.com (NASDAQ:FCSC)
www.streetinsider.com - August 9 at 3:41 PM
biz.yahoo.com logoFIBROCELL SCIENCE, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a Direct Financia (NASDAQ:FCSC)
biz.yahoo.com - August 9 at 3:41 PM
finance.yahoo.com logo8:35 am Fibrocell Science terminates previously announced underwritten public offering, announces convertible debt and warrant financing for up to $25 mln (NASDAQ:FCSC)
finance.yahoo.com - August 9 at 3:41 PM
publicnow.com logoFibrocell Announces Convertible Debt and Warrant Financing of Up to $25 Million (NASDAQ:FCSC)
www.publicnow.com - August 9 at 3:41 PM
capitalcube.com logoFibrocell Science, Inc. :FCSC-US: Earnings Analysis: Q2, 2016 By the Numbers : August 9, 2016 (NASDAQ:FCSC)
www.capitalcube.com - August 9 at 3:41 PM
bizjournals.com logoGene therapy company scraps public stock offering for private financing (NASDAQ:FCSC)
www.bizjournals.com - August 9 at 3:41 PM
finance.yahoo.com logoFibrocell Announces Proposed Public Offering of Common Stock and Warrants (NASDAQ:FCSC)
finance.yahoo.com - August 8 at 5:06 PM
sg.finance.yahoo.com logoFibrocell Science reports 2Q loss (NASDAQ:FCSC)
sg.finance.yahoo.com - August 4 at 5:18 PM
News IconHC Stocks in Front Line: Fibrocell Science Inc (NASDAQ:FCSC), Pfizer Inc. (NYSE:PFE) - share market updates (press release) (NASDAQ:FCSC)
sharemarketupdates.com - August 2 at 9:50 AM
globenewswire.com logoPhase I Data Expected in the Second Half of 2017 (NASDAQ:FCSC)
globenewswire.com - July 29 at 5:03 PM
investornewswire.com logoCan Shares Of Fibrocell Science Inc (NASDAQ:FCSC) Hit $12? - Investor Newswire (NASDAQ:FCSC)
www.investornewswire.com - July 27 at 5:11 PM
publicnow.com logoFibrocell Announces First Subjects Enrolled in Phase I/II Clinical Trial of FCX-007 for Treatment of Recessive Dystrophic Epidermolysis Bullosa (NASDAQ:FCSC)
www.publicnow.com - July 27 at 4:28 PM
biz.yahoo.com logoFIBROCELL SCIENCE, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits (NASDAQ:FCSC)
biz.yahoo.com - July 27 at 4:08 PM
News IconChecking in on Stock Volatility for: Fibrocell Science, Inc. (NASDAQ:FCSC) - Engelwood Daily (NASDAQ:FCSC)
www.engelwooddaily.com - July 22 at 6:19 AM
News IconStock Soars, Rewards Investors Nicely Today: Fibrocell Science, Inc. (NASDAQ:FCSC) - Engelwood Daily (NASDAQ:FCSC)
www.engelwooddaily.com - July 22 at 6:19 AM
investornewswire.com logoIs $12 Price Target Attainable For Fibrocell Science Inc (NASDAQ:FCSC)? - Investor Newswire (NASDAQ:FCSC)
www.investornewswire.com - July 21 at 8:32 AM
News IconHow Many Fibrocell Science Inc (NASDAQ:FCSC)'s Analysts Are Bearish? - Press Telegraph (NASDAQ:FCSC)
presstelegraph.com - July 21 at 8:32 AM
news.cmlviz.com logoFibrocell Science Inc Stock Technicals Hit Extreme Weakness - CML News (NASDAQ:FCSC)
news.cmlviz.com - July 19 at 5:06 PM
kcregister.com logoInovio Pharmaceuticals, Inc. (NASDAQ:INO) Rose 2.36%: Fibrocell Science, Inc. (NASDAQ:FCSC), Bank of America ... - KC Register (NASDAQ:FCSC)
www.kcregister.com - July 19 at 5:06 PM
News IconInvestor Watch: Volatility Recap on Shares of: Fibrocell Science, Inc. (NASDAQ:FCSC) - Engelwood Daily (NASDAQ:FCSC)
www.engelwooddaily.com - July 19 at 5:06 PM
fiscalstandard.com logoFibrocell Science Inc (FCSC) Broker Price Targets For The Coming Week - Fiscal Standard (NASDAQ:FCSC)
www.fiscalstandard.com - July 19 at 5:06 PM
News IconShares Losing Ground in Session: Fibrocell Science, Inc. (NASDAQ:FCSC) - TGP (NASDAQ:FCSC)
telanaganapress.com - July 19 at 5:06 PM
capitalcube.com logoETF’s with exposure to Fibrocell Science, Inc. : July 19, 2016 (NASDAQ:FCSC)
www.capitalcube.com - July 19 at 12:24 PM
News IconShares Experiencing a Downtrend: Fibrocell Science, Inc. (NASDAQ:FCSC) - TGP (NASDAQ:FCSC)
telanaganapress.com - July 16 at 8:24 AM
News IconEye on Stock Volatility for: Fibrocell Science, Inc. (NASDAQ:FCSC) - Engelwood Daily (NASDAQ:FCSC)
www.engelwooddaily.com - July 15 at 6:28 AM
News IconFibrocell Science Incorporated (NASDAQ:FCSC) Short Interest Decreased By 24.38% - Consumer Eagle (NASDAQ:FCSC)
www.consumereagle.com - July 15 at 6:28 AM
News IconFibrocell Science Inc (NASDAQ:FCSC) Institutional Investor Sentiment Trend - Consumer Eagle (NASDAQ:FCSC)
www.consumereagle.com - July 14 at 8:13 AM
investornewswire.com logoStrong Sell Calls For Fibrocell Science Inc (NASDAQ:FCSC) At 0 - Investor Newswire (NASDAQ:FCSC)
www.investornewswire.com - July 14 at 8:13 AM
News IconAre Analysts Bearish Fibrocell Science Inc (NASDAQ:FCSC) After Last Week? - Consumer Eagle (NASDAQ:FCSC)
www.consumereagle.com - July 12 at 10:20 PM
biz.yahoo.com logoFIBROCELL SCIENCE, INC. Files SEC form 8-K, Regulation FD Disclosure, Financial Statements and Exhibits (NASDAQ:FCSC)
biz.yahoo.com - July 12 at 5:11 PM
nasdaq.com logoGilead's Pan-Genotypic HCV Drug Epclusa Gains EU Approval (NASDAQ:FCSC)
www.nasdaq.com - July 11 at 4:58 PM
fiscalstandard.com logoNext Weeks Broker Price Targets For Fibrocell Science Inc (FCSC) - Fiscal Standard (NASDAQ:FCSC)
www.fiscalstandard.com - July 11 at 9:46 AM
finance.yahoo.com logoAmgen Humira Biosimilar Briefing Documents Look Good (NASDAQ:FCSC)
finance.yahoo.com - July 11 at 8:04 AM
publicnow.com logoFibrocell to Present at Cantor Fitzgerald’s 2nd Annual Healthcare Conference (NASDAQ:FCSC)
www.publicnow.com - July 7 at 4:31 PM
investornewswire.com logoFibrocell Science Inc (NASDAQ:FCSC) Expected to Reach Highs Of $12 - Investor Newswire (NASDAQ:FCSC)
www.investornewswire.com - July 7 at 6:28 AM
fiscalstandard.com logoThis Weeks Broker Price Targets For Fibrocell Science Inc (FCSC) - Fiscal Standard (NASDAQ:FCSC)
www.fiscalstandard.com - July 5 at 9:41 AM
News IconFibrocell Science Incorporated (NASDAQ:FCSC) Short Interest Decreased By 24.38% - Press Telegraph (NASDAQ:FCSC)
presstelegraph.com - July 1 at 7:01 AM
bizjournals.com logoChester County gene therapy company cuts its workforce in half (NASDAQ:FCSC)
www.bizjournals.com - June 30 at 5:14 PM
4-traders.com logoFibrocell Science : Expects Significant Cost Savings from Wind-Down of azficel-T Operations (NASDAQ:FCSC)
www.4-traders.com - June 30 at 5:14 PM
News IconAnalyst Rating Update on Fibrocell Science Inc (FCSC) - TheFounders Daily (NASDAQ:FCSC)
www.thefoundersdaily.com - June 30 at 6:47 AM

Social

Fibrocell Science (NASDAQ:FCSC) Chart for Friday, August, 26, 2016


Last Updated on 8/26/2016 by MarketBeat.com Staff